INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,138 | -6.2% | 289 | +20.9% | 0.00% | – |
| Q2 2023 | $9,746 | -9.2% | 239 | -17.0% | 0.00% | – |
| Q1 2023 | $10,734 | +76.8% | 288 | +65.5% | 0.00% | – |
| Q4 2022 | $6,071 | -39.3% | 174 | -2.2% | 0.00% | – |
| Q3 2022 | $10,000 | +11.1% | 178 | +0.6% | 0.00% | – |
| Q2 2022 | $9,000 | -35.7% | 177 | -11.5% | 0.00% | -100.0% |
| Q1 2022 | $14,000 | -41.7% | 200 | +0.5% | 0.00% | 0.0% |
| Q4 2021 | $24,000 | -33.3% | 199 | -24.9% | 0.00% | 0.0% |
| Q3 2021 | $36,000 | +80.0% | 265 | +113.7% | 0.00% | 0.0% |
| Q2 2021 | $20,000 | +66.7% | 124 | -17.3% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | +500.0% | 150 | +328.6% | 0.00% | – |
| Q4 2020 | $2,000 | -90.0% | 35 | -96.5% | 0.00% | -100.0% |
| Q3 2017 | $20,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |